The Company of Biologists
|Agreement labeling||The Company of Biologists Read & Publish agreement|
|Has the agreement been disclosed and published?||No|
|Agreement period||01/01/2021 – 12/31/2023|
|Consortia / Institution||University of Oslo (UiO) incl. Oslo University Hospital|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
|Comments on cost development||No price increase going into or during the agreement|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Fixed price R&P deal|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Unlimited Open Access publishing within the agreement|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY mandatory|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||Publishing costs vs access costs are not explicitly defined in the agreement|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|Comments on workflows||CCC RightsLink|
|OVERALL ASSESSMENT AND COMMENTS||The publication output from UiO is low in this agreement, However, it is important to UiO to secure publishing with smaller publishers and to keep a diversity in publication channels.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|